Asymmetry Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Asymmetry Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,194,530	Closed	-$3.23M	–	46
2020 Q3	$3.23M	Sell	1,194,530 -104,672	-8%	-$290K	2.07%	20
2020 Q2	$3.57M	Buy	+1,299,202	New	+$3.63M	2.74%	16
2019 Q4	–	Sell	-377,399	Closed	-$1.26M	–	42
2019 Q3	$1.26M	Buy	377,399 +101,974	+37%	+$336K	2.71%	15
2019 Q2	$906K	Buy	+275,425	New	+$797K	0.49%	28
2017 Q3	–	Sell	-199,655	Closed	-$643K	–	37
2017 Q2	$643K	Buy	+199,655	New	+$566K	0.76%	26

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Asymmetry Capital Management's ATRS Position: Q4 2020 in Review

Asymmetry Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q4 2020, closing a stake of 1,194,530 shares — an estimated $3.23M sold.

Asymmetry Capital Management first reported a position in ATRS in Q2 2017 and held it in 5 quarters. The position peaked at $3.57M in Q2 2020. 174 funds tracked by Wall St. Rank hold ATRS as of Q4 2020.

Asymmetry Capital Management reported no remaining Antares Pharma, Inc. position as of Q4 2020 after selling out during the quarter.
Asymmetry Capital Management sold 1,194,530 Antares Pharma, Inc. shares in Q4 2020, an estimated $3.23M.
Asymmetry Capital Management first reported a position in Antares Pharma, Inc. in Q2 2017 and held it in 5 quarters.
Asymmetry Capital Management's Antares Pharma, Inc. position peaked at $3.57M in Q2 2020.
174 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2020.

Based on Asymmetry Capital Management's 13F filing for Q4 2020, filed 11 Feb 2021.